Excellent long term survival of front-line high-dose chemotherapy with rituximab (HDT) in

被引:0
|
作者
Dilhuydy, M. [1 ]
Lamy, T. [2 ]
Casassus, P. [3 ]
Deconninck, E. [4 ]
Gressin, R. [5 ]
Le Maignan, C. [6 ]
Milpied, N. [1 ]
机构
[1] CHU Bordeaux, F-93009 Pessac, France
[2] CHU Rennes, F-25030 Rennes, France
[3] Hop Avicenne, Bobigny, France
[4] CHU Besancon, Hematol & BMT Unit, Besancon, France
[5] Hop Michallon, Grenoble, France
[6] Hop Europeen Georges Pompidou, Paris, France
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:147 / 148
页数:2
相关论文
共 50 条
  • [1] Front-line High-Dose Chemotherapy with Rituximab Showed Excellent Long-Term Survival in Adults with Aggressive Large B-Cell Lymphoma: Final Results of a Phase II GOELAMS Study
    Dilhuydy, Marie-Sarah
    Lamy, Thierry
    Foussard, Charles
    Gressin, Remy
    Casassus, Philippe
    Deconninck, Eric
    Le Maignan, Christine
    Damotte, Diane
    Milpied, Noel
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2010, 16 (05) : 672 - 677
  • [2] Front-line high-dose chemotherapy (HDT) combined with rituximab for adults with aggressive large B-cell lymphoma (DLBCL): GOELAMS 074 trial.
    Milpied, NJ
    Lamy, T
    Casassus, P
    Deconninck, E
    Gressin, R
    Maisonneuve, H
    Le Maignan, C
    Ramee, JF
    Tournilhac, O
    Dugay, J
    Legouffe, E
    Delwail, V
    Colombat, P
    BLOOD, 2004, 104 (11) : 258A - 258A
  • [3] Use of high-dose chemotherapy in front-line therapy of childhood malignant glioma
    Massimino, Mauro
    Biassoni, Veronica
    EXPERT REVIEW OF ANTICANCER THERAPY, 2006, 6 (05) : 709 - 717
  • [4] Low-Dose Rituximab and High-Dose Dexamethasone As Front-Line Therapy in Adult Patients with Primary Immune Thrombocytopenia
    Gomez-Almaguer, David
    Tarin-Arzaga, Luz C.
    Moreno-Jaime, Brizio
    Jaime-Perez, Jose C.
    Ceballos-Lopez, Adrian A.
    Ruiz-Argueelles, Guillermo J.
    Ruiz-Delgado, Guillermo J.
    Cantu-Rodriguez, Olga
    Gutierrez-Aguirre, Cesar H.
    BLOOD, 2012, 120 (21)
  • [5] Front-line high-dose chemotherapy (HOT) combined with rituximab for adults with aggressive large B cell lymphoma (DLBCL). A pilot study by the GOELAMS
    Milpied, NJ
    Lamy, T
    Casassus, P
    Deconninck, E
    Gressin, R
    Le Maignan, C
    Tournilhac, O
    Dugay, J
    Legouffe, E
    Delwail, V
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 598S - 598S
  • [6] Long-term clinical and molecular follow-up of follicular or transformed lymphoma patients following front-line high-dose sequential (HDS) chemotherapy.
    Tarella, C
    Corradini, P
    Caracciolo, D
    Gavarotti, P
    Bianchi, A
    Astolfi, M
    Zaglio, F
    Pileri, A
    BLOOD, 1997, 90 (10) : 501 - 501
  • [7] OUTCOME AFTER HIGH-DOSE ETOPOSIDE AND MELPHALAN AND AUTOTRANSPLANT IN PATIENTS FAILING FRONT-LINE CHEMOTHERAPY FOR HODGKINS-DISEASE
    PRINCE, HM
    CRUMP, M
    IMRIE, K
    STEWART, K
    GIROUARD, C
    KEATING, A
    EXPERIMENTAL HEMATOLOGY, 1995, 23 (08) : 858 - 858
  • [8] The Effects of Rituximab Added to Front-Line or Salvage Chemotherapy in Diffuse Large B-Cell Lymphoma (DLBCL) Undergoing High-Dose Chemotherapy (HDC) and Autologous Stem Cell Transplant (ASCT)
    Ashraf, Umeer
    Mahajan, Ritika
    Hahn, Theresa
    Smiley, Shannon L.
    McCarthy, Philip L.
    Bernstein, Zale P.
    Chanan-Khan, Asher Alban
    Battiwala, Minoo
    Czuczman, Myron S.
    Hernandez-Lizaliturri, Francisco J.
    BLOOD, 2008, 112 (11) : 415 - 416
  • [9] High-dose chemotherapy and in vivo rituximab purged autologous stem cell transplantation as front-line therapy for mantle-cell lymphoma in patients aged up to 70 years
    Andreini, A
    Sorio, M
    Andreoli, A
    Krampera, M
    de Sabata, D
    Ledro, S
    Di Bella, R
    Benedetti, F
    BONE MARROW TRANSPLANTATION, 2006, 37 : S238 - S238
  • [10] High-dose therapy and ASCT versus conventional therapy for patients with advanced Hodgkin's lymphoma responding to front-line therapy: Long term results
    Carella, A. M.
    Bellei, M.
    Brice, P.
    Gisselbrecht, C.
    Visani, G.
    Colombat, P.
    Fabbiano, F.
    Donelli, A.
    Feugier, P.
    Browett, P.
    Hagberg, H.
    Federico, M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 33 - 33